» Articles » PMID: 22916254

Effects of Rs7903146 Variation in the Tcf7l2 Gene in the Lipid Metabolism of Three Different Populations

Abstract

Background: TCF7L2 rs7903146 is an important genetic factor predicting type 2 diabetes (T2DM) which has also been linked to higher cardiovascular risk. To date, there is little information about the additional impact of this single nucleotide polymorphism (SNP) beyond glucose metabolism.

Methodology/principal Findings: We studied whether rs7903146 influenced postprandial lipid metabolism in three different populations (healthy young men, metabolic syndrome (MetS) patients and elderly persons). Eighty-eight healthy males were submitted to a single saturated fatty acid-rich test meal. Additionally, 110 middle-aged MetS patients and 20 healthy elderly persons (≥ 65 years) were submitted to three different dietary models followed by test meals. Minor allele homozygotes for rs7903146 showed a worse postprandial lipemia profile in young males, as seen by a lower HDL-cholesterol and Apo A1 concentration during the postprandial lipemia and a trend towards higher triglycerides (TG), than the other genotypes. In healthy elderly persons, carriers of the minor allele showed higher total cholesterol, LDL-cholesterol, Apo B and TG in the fasting state, and a higher postprandial area under the curve for total cholesterol, Apo B, small-triglyceride rich lipoprotein (TRL) cholesterol and small-(TRL) triglycerides. These results were accompanied by differential changes in adipokines. We did not observe any influence of rs7903146 on the postprandium of MetS patients.

Conclusions/significance: Healthy young males and elderly persons who are carriers of the mutant allele for rs7903146 have an impaired postprandial lipid metabolism that may be mediated by an alteration in adipokine regulation, and may be related to the higher cardiovascular risk observed in these persons.

Trial Registration: ClinicalTrials.gov NCT00429195.

Citing Articles

Changes in triglyceride-rich lipoprotein particle profiles in response to one-week on a low fat or Mediterranean diet by TCF7L2 rs7903146 genotype: a randomized crossover dietary intervention trial.

Lai C, Gervis J, Parnell L, Lichtenstein A, Ordovas J Genes Nutr. 2025; 20(1):4.

PMID: 40050721 PMC: 11884055. DOI: 10.1186/s12263-025-00763-y.


Integrated Analysis of Genomic and Genome-Wide Association Studies Identified Candidate Genes for Nutrigenetic Studies in Flavonoids and Vascular Health: Path to Precision Nutrition for (Poly)phenols.

Ruskovska T, Postolov F, Milenkovic D Nutrients. 2024; 16(9).

PMID: 38732608 PMC: 11085427. DOI: 10.3390/nu16091362.


Sbp2l contributes to oligodendrocyte maturation through translational control in Tcf7l2 signaling.

Yugami M, Hayakawa-Yano Y, Ogasawara T, Yokoyama K, Furukawa T, Hara H iScience. 2024; 26(12):108451.

PMID: 38213786 PMC: 10783607. DOI: 10.1016/j.isci.2023.108451.


Association of TCF7L2 Variants in Type 2 Diabetes Mellitus with Hypertriglyceridemia - A Case-Control Study.

Gunavathy N, Balaji R, Kumaravel V Indian J Endocrinol Metab. 2023; 27(4):346-350.

PMID: 37867984 PMC: 10586556. DOI: 10.4103/ijem.ijem_35_23.


gene associated postprandial triglyceride dysmetabolism- a novel mechanism for diabetes risk among Asian Indians.

Madhu S, Mishra B, Mannar V, Aslam M, Banerjee B, Agrawal V Front Endocrinol (Lausanne). 2022; 13:973718.

PMID: 36263318 PMC: 9573951. DOI: 10.3389/fendo.2022.973718.


References
1.
Schinner S . Wnt-signalling and the metabolic syndrome. Horm Metab Res. 2009; 41(2):159-63. DOI: 10.1055/s-0028-1119408. View

2.
Grundy S, Brewer Jr H, Cleeman J, Smith Jr S, Lenfant C . Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004; 24(2):e13-8. DOI: 10.1161/01.ATV.0000111245.75752.C6. View

3.
Florez J . Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?. Diabetologia. 2008; 51(7):1100-10. DOI: 10.1007/s00125-008-1025-9. View

4.
Fukushima H, Sugiyama S, Honda O, Koide S, Nakamura S, Sakamoto T . Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. J Am Coll Cardiol. 2004; 43(12):2219-24. DOI: 10.1016/j.jacc.2003.09.074. View

5.
Stalenhoef A, de Graaf J . Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol. 2008; 19(4):355-61. DOI: 10.1097/MOL.0b013e328304b63c. View